SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Rennova Health, Inc. (RNVAW) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 27/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — RNVAW
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio14.84
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2012 |
$-0.77 |
$100K |
$-1.43M |
-1429% |
| 2013 |
$-2.12 |
$400K |
$-3.93M |
-982% |
| 2014 |
$-1.69 |
$658K |
$-3.31M |
-503.6% |
| 2016 |
$-30.17 |
$1.7M |
$-32.61M |
-1923.8% |
| 2018 |
$-1.40 |
$14.55M |
$-14.02M |
-96.4% |
| 2019 |
$-0.01 |
$15.99M |
$-48.03M |
-300.5% |
| 2020 |
$0.00 |
$7.2M |
$-18.34M |
-254.7% |
| 2021 |
$-913.37 |
$3.22M |
$5.61M |
173.9% |
| 2022 |
$-0.03 |
$13.04M |
$-3.29M |
-25.3% |
| 2023 |
$0.00 |
$18.69M |
$-7.73M |
-41.4% |
